Topical ophthalmic drugs and the pediatric patient

Optometry

Volumn 71, Issue 8, 2000, Pages 511-518

  Chung, Ida ^a   Buhr, Victoria ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Children dosing; Medications; Pediatric ophthalmic dosage; Topical ophthalmic drugs

Indexed keywords

DRUG; EYE DROPS;

ARTICLE; CHILD; DRUG LABELING; DRUG UTILIZATION; EYE DISEASE; FACTUAL DATABASE; HUMAN; INFANT; PRESCHOOL CHILD; SAFETY; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; CHILD; CHILD, PRESCHOOL; DATABASES, FACTUAL; DRUG LABELING; DRUG UTILIZATION; EYE DISEASES; HUMANS; INFANT; OPHTHALMIC SOLUTIONS; PHARMACEUTICAL PREPARATIONS; SAFETY;

EID: 0041118252     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Food and Drug Administration, Department of Health and Human Services. "Specific Requirements on Content and Format of Labeling for Human Prescription Drugs; Revision of 'Pediatric Use' Subsection in the Labeling." Docket No. 92N-0165. 12/13/94. www.fda.gov/cder/pediatric
2. Kauffman Richard (1996). Testimony by the American Academy of Pediatrics Before the Subcommittee on Human Resources and Intergovernmental Relations Government Reform and Oversight Committee U.S. House of Representatives "Off-Label Drug Use and FDA Review of Supplemental Drug Approval" [Online]. Available: http://www. aap.org.htm [1999, June 25].
3. Food and Drug Administration, Department of Health and Human Services. "FDA Acts to Make Drugs Safer for Children" 11/27/98. www.fda.gw/bbs/topics/NEWS/NEW00666.htm
4. MEDLARS Management Section, National Library of Medicine. PubMed Training Workbook for End-Users. Bethesda, Md.: National Library of Medicine, July 1998:83.
5. Physician's Desk Reference (PDR]. Montrale, N.J.: Medical Economics Company, Inc., 1999
6. Roper FW and Boorkman JA. Introduction to reference sources in the health sciences, 3rd ed. Metuchen, N.J.: Medical Library Association, 1994:143-70.
7. Drug Facts and Comparisons. St. Louis: Facts and Comparisons, 1999.
8. Ophthalmic Drug Facts 1999. St. Louis: Facts and Comparisons, 1999.
9. AHFS (Amercian Hospital Formulary Service) Drug Information. Bethesda, Md.: American Society of Health-System Pharmacists, Inc., 1999.
10. The Medical Letter on Drugs and Therapeutics. New Rochelle: N.Y.: The Medical Letter, Inc., 1999.
11. USPDispensing Information (USP DI). Drug information for the healthcare professional, vol. I. Englewood, Colo.: Micromedex, 1999.
12. Handbook of nonprescription drugs. Washington, D.C.: American Pharmaceutical Association, 1996.
13. Allergan Pharmaceuticals (ed.). (© 1997). Allergan Pharmaceuticals Online, [Online]. Available: http://www. allergan.com/ [1999, May 17].
14. Glaxo Wellcome Inc. (ed.). (© 1996-1999). Glaxo Wellcome Inc., [Online], Available: http://www.glaxowellcome.com [1999 May 17].
15. Pharmacia & Upjohn (ed.). Pharmacia & Upjohn, [Online]. Available: http://www.upjohn.com/home.asp [1999, May 17].
16. Reents S and Seymour T. Clinical pharmacology: an electronic drug reference and teaching guide. Gainesville, Fla.: Gold Standard Multimedia, Inc., year?
17. Barlett JD and Jaanus SD. Clinical ocular pharmacology, 3rd ed. Newton, Mass.: Butterworth-Heinemann, 1995: 3-47, 151-82.
18. Shell JW. Pharmacokinetics of topically applied ophthalmic drugs. Surv Ophthalmol 1982:26;207-218.
19. Palmer EA. How safe are ocular drugs in pediatrics? Ophthalmology 1986:93;1038-40.
20. Hathaway , Groothuis , need 3rd author name and initials, et al. Current pediatric diagnosis and treatment, 10th ed. Norwalk, Conn.: Appleton and Lange, 1991:294-5.
21. Melton R and Thomas R. The 1997 clinical guide to ophthalmic drugs. Rev Optometry, May 1997.
22. Melton R and Thomas R. The 1999 clinical guide to ophthalmic drugs. Rev Optometry, July 1999.
23. Woodard DR and Woodard RB. Drugs in primary eye care. Stamford, Conn.: Appleton and Lange, 1997.
24. Mosby's Gen Rx. St. Louis: Mosby-Yearbook, Inc., 1998.